Stay updated on Zimura for AMD: Phase 3 Clinical Trial
Sign up to get notified when there's something new on the Zimura for AMD: Phase 3 Clinical Trial page.

Latest updates to the Zimura for AMD: Phase 3 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision tag v3.5.4 was added and the previous tag v3.5.3 was removed. This updates the page's revision metadata to reflect the latest version.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe publication entry for the two-year GATHER2 results has been updated from an online-ahead-of-print record to a final Ophthalmology 2026 April issue citation with volume/issue/page numbers. The page also reflects a new site revision version string.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded Padova, Italy, 35128 and removed Padua, Italy, 35128 from the Locations list.SummaryDifference0.0%

- Check67 days agoChange DetectedAddition of Revision: v3.5.0 and removal of Revision: v3.4.3.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check96 days agoChange DetectedA new bibliographic entry was added to Publications: Khanani et al. Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial. The prior entry with slightly different capitalization and wording (2-year efficacy and safety results from the GATHER2 phase 3 trial) was removed.SummaryDifference0.0%

Stay in the know with updates to Zimura for AMD: Phase 3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zimura for AMD: Phase 3 Clinical Trial page.